We partner with leading pharmaceutical, biotechnology, and diagnostic companies to support and strengthen OCRA's mission.
As the leading ovarian cancer organization in the world, we recognize that stakeholder collaboration is key to achieving our goal of curing gynecologic cancers and ensuring the development of safe, more effective therapies. We work with our partners to fulfill our shared goals of raising awareness, supporting patients, emphasizing education, and advancing critical research and treatment options.
Partnering with OCRA helps bring your clinical work full circle, supporting patients through every stage of their journeys. By collaborating with us, industry partners gain a better understanding of patient needs, helping ensure developments that address their concerns, while gaining an increased focus on real-world data.
We have a number of year-round sponsorship and support opportunities for partners, from patient support and education, to advocacy, to our International Conference, as well as our Gynecologic Cancer Collaborative. OCRA also engages with partners to increase awareness through unbranded communications campaigns and opportunities to elevate the patient voice in therapy development. Please contact us if you wish to learn more about our work and how we can partner to better serve and support the gynecologic cancer community.
At present, OCRA does not engage with partners for paid advertisements on our website or digital/print publications and newsletters. We do have opportunities for brand awareness and advertisements via our International Gynecologic Cancer Conference.
For more information, please contact Jessica Hughson-Andrade at jhughson-andrade@ocrahope.org
Friends, As we approach the end of the year, one thing stands out above all else: this is a moment of unprecedented opportunity to accelerate progress against ovarian and all gynecologic cancers. And thanks to you, OCRA is rising to meet that moment — driving innovation, expanding support, and providing the community that so many … Continued
Ovarian Cancer Research Alliance (OCRA) congratulates board member Laura Shawver, PhD, on her selection to the Fierce 50 of 2025, a leading industry award from Fierce Life Sciences recognizing individuals and organizations advancing what’s possible in health, science and patient care. Dr. Shawver was selected for her long-standing leadership in oncology research and drug development, … Continued
On GivingTuesday, YOU Can Help Shape the Future of Ovarian and Gynecologic Cancer Care GivingTuesday gifts—including early gifts—will be matched by a generous OCRA board member, dollar for dollar, up to $500,000. That means your $1 = $2 to improve care, foster hope, and bring us closer to a cure. Ovarian Cancer Research Alliance (OCRA) … Continued
Get email updates about research news, action alerts, and ways to join the fight.
